Jun 19 |
Eli Lilly: The Party Is Probably Nearing The End
|
Jun 18 |
(LLY) - Analyzing Eli Lilly and Co's Short Interest
|
Jun 18 |
Why the GLP-1 impact on other industries 'will take years'
|
Jun 18 |
Eli Lilly oral weight-loss candidate orfoglipron is potential winner: SA Investing Summit
|
Jun 17 |
Eli Lilly And Alzheimer's Disease: The Paucity Of Progress
|
Jun 17 |
Stocks close higher, Trump tax cuts: Market Domination Overtime
|
Jun 17 |
Eli Lilly unveils new North Carolina plant for GLP-1 drugs
|
Jun 17 |
New Weight-Loss Drugs and Devices Are Coming This Week
|
Jun 17 |
Top Weight-Loss Rivals Share This Risk After Eye-Popping Runs
|
Jun 17 |
Broadcom Is on Track to Edge Past Eli Lilly’s Market Value. AI Is Helping It Do So.
|